Lihong Wang-Bishop

783 total citations
10 papers, 539 citations indexed

About

Lihong Wang-Bishop is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lihong Wang-Bishop has authored 10 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Lihong Wang-Bishop's work include interferon and immune responses (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (2 papers). Lihong Wang-Bishop is often cited by papers focused on interferon and immune responses (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (2 papers). Lihong Wang-Bishop collaborates with scholars based in United States. Lihong Wang-Bishop's co-authors include John T. Wilson, Kyle W. Becker, Max E. Jacobson, Justin M. Balko, Daniel Shae, Mohamed Wehbe, Kyle M. Garland, Kelli L. Boyd, Jessalyn J. Baljon and Marjan Rafat and has published in prestigious journals such as ACS Nano, Gastroenterology and Journal of Controlled Release.

In The Last Decade

Lihong Wang-Bishop

10 papers receiving 532 citations

Peers

Lihong Wang-Bishop

IMMUN

MB

ONCOL

BE

ID

João Paulo Portela Catani Belgium

Faezzah Baharom Sweden

Vinod Nadella India

Neeraja Dharmaraj United States

Beatriz Martins Finland

Nicolas Boisgerault France

Blake Flood United States

Michal M. Raczy United States

Shurong Zhou United States

Francis Combes Belgium

João Paulo Portela Catani Belgium

Lihong Wang-Bishop

370 ×1.1

IMMUN

211 ×0.9

MB

251 ×2.3

ONCOL

66 ×0.7

BE

51 ×0.6

ID

Citations per year, relative to Lihong Wang-Bishop Lihong Wang-Bishop (= 1×) peers João Paulo Portela Catani

Countries citing papers authored by Lihong Wang-Bishop

Since Specialization

Citations

This map shows the geographic impact of Lihong Wang-Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Wang-Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Wang-Bishop more than expected).

Fields of papers citing papers by Lihong Wang-Bishop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Wang-Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Wang-Bishop. The network helps show where Lihong Wang-Bishop may publish in the future.

Co-authorship network of co-authors of Lihong Wang-Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Wang-Bishop. A scholar is included among the top collaborators of Lihong Wang-Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Wang-Bishop. Lihong Wang-Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Wang-Bishop, Lihong, Mohamed Wehbe, Jinming Yang, et al.. (2024). Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy. ACS Nano. 18(18). 11631–11643. 13 indexed citations

2.

Becker, Kyle W., Kyle M. Garland, Karan Arora, et al.. (2022). A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA. Journal of Controlled Release. 345. 354–370. 26 indexed citations

3.

Lu, Heng, Lihong Wang-Bishop, Farah Ballout, et al.. (2022). Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma. Cancers. 14(6). 1401–1401. 8 indexed citations

4.

Garland, Kyle M., Lihong Wang-Bishop, Ann Hanna, et al.. (2021). Pharmacological Activation of cGAS for Cancer Immunotherapy. Frontiers in Immunology. 12. 753472–753472. 17 indexed citations

5.

Wang-Bishop, Lihong, Mohamed Wehbe, Daniel Shae, et al.. (2020). Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. Journal for ImmunoTherapy of Cancer. 8(1). e000282–e000282. 129 indexed citations

6.

Wehbe, Mohamed, Lihong Wang-Bishop, Kyle W. Becker, et al.. (2020). Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. Journal of Controlled Release. 330. 1118–1129. 92 indexed citations

7.

Baljon, Jessalyn J., et al.. (2019). The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome. Biomaterials Science. 7(5). 1888–1897. 22 indexed citations

8.

Knight, Frances C., Pavlo Gilchuk, Amrendra Kumar, et al.. (2019). Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8⁺ Lung-Resident Memory T Cells. ACS Nano. 13(10). 10939–10960. 108 indexed citations

9.

Wang-Bishop, Lihong, Zheng Chen, A. Craig Lockhart, et al.. (2018). Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Gastroenterology. 156(3). 662–675.e7. 71 indexed citations

10.

Jacobson, Max E., Lihong Wang-Bishop, Kyle W. Becker, & John T. Wilson. (2018). Delivery of 5′-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy. Biomaterials Science. 7(2). 547–559. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact